Alteplase as hemodialysis catheter locking solution and spurious hyperphosphatemia

J Vasc Access. 2011 Jul-Sep;12(3):269. doi: 10.5301/JVA.2011.6220.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Biomarkers / blood
  • Catheterization, Central Venous / adverse effects*
  • Child, Preschool
  • Diagnostic Errors / prevention & control
  • Female
  • Fibrinolytic Agents / adverse effects*
  • Greece
  • Humans
  • Hyperphosphatemia / blood
  • Hyperphosphatemia / chemically induced*
  • Hyperphosphatemia / diagnosis
  • Male
  • Middle Aged
  • Phosphorus / blood
  • Predictive Value of Tests
  • Renal Dialysis*
  • Reproducibility of Results
  • Tissue Plasminogen Activator / adverse effects*
  • Upper Extremity Deep Vein Thrombosis / drug therapy*
  • Upper Extremity Deep Vein Thrombosis / etiology

Substances

  • Biomarkers
  • Fibrinolytic Agents
  • Phosphorus
  • Tissue Plasminogen Activator